Bays, H. E., Toth, P., Alkhouri, N., Pullman, J., Freilich, B., Neutel, J., . . . Lian, B. (2026). Weekly Subcutaneous VK2735 , a GIP / GLP ‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study. Wiley. https://doi.org/10.1002/oby.70106
Chicago Style (17th ed.) CitationBays, Harold E., et al. Weekly Subcutaneous VK2735 , a GIP / GLP ‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study. Wiley, 2026. https://doi.org/10.1002/oby.70106.
MLA (9th ed.) CitationBays, Harold E., et al. Weekly Subcutaneous VK2735 , a GIP / GLP ‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study. Wiley, 2026. https://doi.org/10.1002/oby.70106.
Warning: These citations may not always be 100% accurate.